Jörg Hoffmann

1.6k citations
54 papers · 1.3k · 1 hit paper · h-index 22

Impact in

  • Genetics top 5%
    • Inflammatory Bowel Disease
  • Immunology top 10%
    • T-cell and B-cell Immunology
    • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
    • Immunotherapy and Immune Responses

Papers in

Jörg Hoffmann

49 papers receiving 1.3k citations

Jörg Hoffmann's Hit Papers

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study 2024 · 71 citations
710+1Years since publication204060

Peers

Jörg Hoffmann
Comparison fields: 5 of 95
  • Genetics 553
  • Immunology 270
  • Immunology and Allergy 55
  • Gastroenterology 48
  • Parasitology 32
Replace Yasuyo Shimomura with:
Yasuyo Shimomura Japan
Leslie Saurer Switzerland
Anders Kirch Dige Denmark
Robbyn Sockolow United States
Jeffrey D. McCurdy Canada
Yutaka Kanamori Japan
Marielle Cohard France
Josiah F. Wedgwood United States
Kenneth A. Huizenga United States
Jocelyn Celestin United States
Jörg Hoffmann relative to Yasuyo Shimomura Japan Yasuyo Shimomura's profile →
Citations per field
00.5×2×3×4×5×
Yasuyo Shimomura · 1×
Citations per year

Countries citing papers authored by Jörg Hoffmann

Since Specialization
Citations

This map shows the geographic impact of Jörg Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hoffmann more than expected).

Fields of papers citing papers by Jörg Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hoffmann. The network helps show where Jörg Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Jörg Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jörg Hoffmann Line = papers co-authored together Jörg Hoffmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007164
2 200996
3 200884
4 200682
5
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
Hit paper breakdown →
202471
6 200169
7 200166
8 200863
9 199755
10 200952
11 200637
12 199234
13 200733
14 200932
15 199331
16 200228
17 199526
18 200226
19 200826
20 199725

About Jörg Hoffmann

Jörg Hoffmann is a scholar working on Genetics, Immunology, Rheumatology, Immunology and Allergy and Surgery, having authored 54 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (24 papers), T-cell and B-cell Immunology (8 papers), Rheumatoid Arthritis Research and Therapies (4 papers), Cell Adhesion Molecules Research (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers), Clinical practice guidelines implementation (2 papers), Lymphoma Diagnosis and Treatment (2 papers) and IgG4-Related and Inflammatory Diseases (2 papers). The work is most often cited by research in Genetics (553 citations), Immunology (270 citations), Immunology and Allergy (55 citations), Gastroenterology (48 citations) and Parasitology (32 citations). Jörg Hoffmann has collaborated with scholars based in Germany, Poland and Switzerland. Frequent co-authors include Martin Zeitz, Christoph Loddenkemper, Anja Andrea Kühl, Jürgen Westermann, Nina N. Pawlowski, Katja Grollich, Britta Engelhardt, Dietlind Schleiermacher, Henning K. Zeidler and Markus Janotta. Their work appears in journals such as International Journal of Colorectal Disease, European Journal of Immunology, Clinical & Experimental Immunology, Digestion and Investigative Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact